2 unknown. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
| Phase 1 | 1 | Unknown 1 |
Follow KB105: new trials by email Literature Review of KB105 trials Research Report on KB105
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Topical KB105 for the Treatment of TGM1-deficient Autosomal Recessive Congenital Ichthyosis (ARCI) KB105, Placebo - Autosomal Recessive Ichthyosis | Phase 2 | Unknown | Krystal Biotech, Inc. | 15 | 2023-03-01 | 2023-02-23 |
| Topical KB105 Gene Therapy for the Treatment of TGM1-deficient Autosomal Recessive Congenital Ichthyosis (ARCI) KB105 - TGM-1 Related Autosomal Recessive Congenital Ichthyosis | Phase 1 / Phase 2 | Unknown | Krystal Biotech, Inc. | 6 | 2019-08-27 | 2021-09-13 |
United States (2)